Cardiovascular (CV)

European Society of Hypertension (ESH) 2026

Congress Details

May 28-31, 2026

Glasgow, Poland

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Agenda

30 May, 2026

Presentation Type

Oral Presentation

Time

16:55-17:10 CEST

Location

Blue Room

Title

KARDIA-3: Zilebesiran as Add-on Therapy in Adults With Hypertension and Established Cardiovascular Disease or High Cardiovascular Risk With and Without Chronic Kidney Disease

Presenter